OPRXNasdaqServices-Business Services, NECFiscal year ends December 31

OptimizeRx Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$8.74+0.24 (+2.82%)

Close on Oct 19, 2026

Market cap: $164.19M
P/E (TTM): 36.4
Dividend yield: –

OptimizeRx Corp income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31
Revenue	109	92	72	62	61	43	25	21	12	7.75	7.22	6.50	4.68	1.99	1.11	0.07
Cost of Revenue	36	33	29	23	26	19	9.16	9.00	–	–	–	–	–	–	–	–
Gross Profit	74	59	43	39	36	24	15	12	5.95	4.34	3.60	3.28	2.82	1.87	–	–
Research & Development	0	0	–	–	–	0	1.60	0	–	–	–	–	–	–	–	–
Selling, General & Admin	–	–	–	33	28	–	–	–	–	–	–	–	–	–	–	–
General & Administrative	–	–	–	–	–	–	–	–	–	–	–	–	0.29	0.27	0.45	–
Advertising Expenses	0.45	1.05	0.78	–	–	–	–	–	–	–	–	–	0.05	0.06	0.54	–
Operating Expenses	62	73	69	51	35	26	19	12	8.08	5.92	4.20	4.31	3.09	2.33	2.57	1.92
Operating Income	12	-14	-26	-12	0.36	-2.14	-3.69	0.18	-2.13	-1.58	-0.60	-1.03	-0.27	-0.45	-1.45	-1.85
Interest Expense	5.29	6.16	1.45	–	–	–	–	–	–	–	0	0	0	0.00	0.96	-0.11
Interest & Investment Income	0.35	0.33	2.19	0.85	0.02	0.07	0.29	0.05	0.03	0.04	–	–	–	–	–	–
Other Non-Operating Income	-4.74	-5.68	1.24	0.85	0.02	-0.07	-0.35	0.05	0.03	0.04	0.00	0.00	0.00	–	–	–
Asset Impairment Charges	0.37	7.49	6.74	–	–	–	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	-1.31	–	–	–	–	0.00	-0.07	0	-0.03	0.00	0	–	–	–
Legal Settlements	–	–	–	–	–	–	–	–	–	-0.05	0	-0.40	0	–	–	–
Pretax Income	6.95	-19	-25	-11	0.38	-2.21	-4.04	0.23	-2.10	-1.54	-0.60	-1.03	-0.27	–	–	–
Income Tax Expense	1.82	0.73	-7.60	–	–	–	-0.90	–	–	–	0	0	0	–	–	–
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	–	–	–	0.22	-0.45	-2.12	-2.01
Net Income incl. Noncontrolling Interests	–	–	–	–	0.38	-2.21	-3.14	0.23	–	–	–	–	–	–	-2.12	-2.01
Net Income	5.13	-20	-18	-11	0.38	-2.21	-3.14	0.23	-2.10	-1.54	-0.60	-1.03	-0.27	-0.45	-2.12	–
Net Income to Common	5.13	-20	-18	-11	0.38	-2.21	-3.14	0.23	–	–	–	–	–	–	–	–
EPS (Basic)(per share)	0.28	-1.10	-1.03	-0.64	0.02	-0.15	-0.23	0.02	-0.21	-0.15	-0.06	-0.12	-0.06	–	–	–
EPS (Diluted)(per share)	0.27	-1.10	-1.03	-0.64	0.02	-0.15	-0.23	0.02	-0.21	-0.15	–	-0.12	-0.06	–	–	–
Shares Outstanding (Basic, Weighted)(shares)	19	18	17	18	17	15	13	11	9.82	9.90	8.19	7.46	4.80	5.74	–	–
Shares Outstanding (Diluted, Weighted)(shares)	19	18	17	18	18	15	13	12	9.82	9.90	8.19	8.00	7.07	5.74	–	–
EBITDA	16	-9.38	-24	-10	2.33	-0.06	-2.41	0.50	-1.81	-1.35	-0.26	-0.76	-0.07	-0.27	-1.31	-1.79

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 73.2%
Operating margin: 11.1%
Net margin: 4.7%
Return on equity, FY2025: 4.2%

Financial strength

Current ratio: 5.58
Debt to equity: 0.15
Debt to assets: 11.6%
Cash to current liabilities: 248.1%

Valuation

P/E ratio: 36.4
Price to sales: 1.66
Price to book: 1.25
Dividend yield: –